Okta, Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Okta, Inc. trades at $136.01 (market cap $24.63B), while Health Care Select Sector SPDR Fund trades at $159.56. Which is the better fit depends on your goals.
| OKTA | XLV | |
|---|---|---|
Market Cap | $24.63B | — |
Sector | Technology | — |
52-Week High | $154.62 | $164.48 |
52-Week Low | $62.93 | $129.01 |
Enterprise Value | $22.45B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.
XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.
Trailing returns across standard periods
Latest headlines on both assets
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →